Phase 2 Trial of Pembrolizumab, Ixazomib, and Dexamethasone for Relapsed Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2019
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Pembrolizumab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 14 Nov 2019 Status changed from recruiting to suspended.
- 09 Oct 2019 Status changed from suspended to recruiting.
- 09 Jan 2019 Status changed from recruiting to suspended.